NOVAVAX INC Financial Ratios
NVAX / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-
Profit Margin
39.2%
Net Income / Revenue
Asset Turnover
0.95
Revenue / Total Assets
Equity Multiplier
-9.21
Total Assets / Equity
Profitability
Liquidity
Current Ratio
2.13
Quick Ratio
2.10
Solvency
Interest Coverage
-21.22
Efficiency
Asset Turnover
0.95
Inventory Turnover
6.33
Days Sales Outstanding
35 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
+50.0%
+56.5pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.